Singapur - anglès - HSA (Health Sciences Authority)

all eights (singapore) private limited - immunology - antigenic assay of antithrombin (at) concentration by the immune-turbidimetric method.

Singapur - anglès - HSA (Health Sciences Authority)

all eights (singapore) private limited - immunology - intended for use with analyzers of the sta® line suitable with these reagents, for the quantitative determination of antithrombin (at) activity level in plasma by the synthetic chromogenic substrate method.

Singapur - anglès - HSA (Health Sciences Authority)

biomed diagnostics pte ltd - hematology - automated chromogenic assay for the quantitative determination of antithrombin in human citrated plasma on the il coagulation systems.

Singapur - anglès - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - hematology - cobas integra antithrombin is an in vitro test for the quantitative determination of antithrombin activity in human plasma on cobas integra systems.

Singapur - anglès - HSA (Health Sciences Authority)

sysmex asia pacific pte. ltd. - hematology - innovance antithrombin is a chromogenic assay for the automatic quantification of functionally active antithrombin in human citrated plasma. the assay is suitable for diagnosis of congenital or acquired antithrombin deficiencies, which are associated with a high risk of thrombosis. innovance antithrombin assay can be used for monitoring substitution therapy with antithrombin concentrates.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

leo pharma - antithrombin alfa - powder for solution for infusion - 1750unit

Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

japan blood products organization - antithrombin gamma(genetical recombination) - injection

Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

japan blood products organization - antithrombin gamma(genetical recombination) - injection

Singapur - anglès - HSA (Health Sciences Authority)

dch auriga singapore - desogestrel (in blue tablet); desogestrel (in white tablet); ethinylestradiol (in blue tablet); ethinylestradiol (in white tablet) - tablet - 25 mcg - desogestrel (in blue tablet) 25 mcg; desogestrel (in white tablet) 125 mcg; ethinylestradiol (in blue tablet) 40 mcg; ethinylestradiol (in white tablet) 30 mcg

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diagnostica stago pty ltd - ct876 - thrombophilia and coagulation inhibitor ivds - ivds that are intended to be used in testing to provide information about thrombosis or the abnormal development of clots, and inhibitors of the coagulation process. activated protein c resistance ratio (apcr), activated protein c resistant factor v (factor v leiden), antithrombin iii (atiii), coagulation factor ii inhibitor, coagulation factor ix inhibitor, coagulation factor vii inhibitor, coagulation factor viii inhibitor, coagulation factor x inhibitor, coagulation factor xa inhibitor, coagulation factor xi inhibitor, coagulation factor xii inhibitor, coagulation inhibitory substance neutralization, endogenous thrombin potential (etp), heparin anti-xa, heparin cofactor ii, hirudin, lupus anticoagulant marker, multiple thrombophilia marker, protein c, protein c, protein z, prothrombin fragment 1 + 2, thrombin-antithrombin iii complex (tat)